首页>
外国专利>
ANTI-HCV MONOCLONAL ANTIBODY AS A MEDICAMENT FOR THE THERAPEUTIC TREATMENT AND PREVENTION OF HCV INFECTIONS
ANTI-HCV MONOCLONAL ANTIBODY AS A MEDICAMENT FOR THE THERAPEUTIC TREATMENT AND PREVENTION OF HCV INFECTIONS
展开▼
机译:抗HCV单克隆抗体作为治疗性治疗和预防HCV感染的药物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the monoclonal antibody e20 or a functional fragment thereof as a medicament for the therapeutic treatment and prevention of HCV infections. The e20 antibody is able to bind all of the known HCV genotypes and exhibits a strong neutralising activity against the virus, in particular towards genotypes 1a, 1b, 2a, and 4. A pharmaceutical composition is also described for the treatment or prevention of HCV infections, which comprises the monoclonal antibody e20 or a functional fragment thereof, and pharmaceutically acceptable excipients, carriers or diluents.
展开▼